The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID.

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Interstitial Lung DiseaseSARS-CoV-2 Infection
Trial Locations (1)

Unknown

RECRUITING

Imperial College Healthcare trust, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

University of Nottingham

OTHER

collaborator

University of Southampton

OTHER

collaborator

University of Leicester

OTHER

collaborator

University of Manchester

OTHER

collaborator

University of Liverpool

OTHER

collaborator

University of Sheffield

OTHER

collaborator

University of Oxford

OTHER

collaborator

University College, London

OTHER

collaborator

University of Newcastle Upon-Tyne

OTHER

collaborator

University of Edinburgh

OTHER

lead

Imperial College London

OTHER

NCT05514522 - The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID. | Biotech Hunter | Biotech Hunter